Lior Teitelbaum
Direktor/Vorstandsmitglied bei Protekt Therapeutics Ltd.
Aktive Positionen von Lior Teitelbaum
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
Johnson & Johnson Innovation - JJDC, Inc.
 Johnson & Johnson Innovation - JJDC, Inc. Investment ManagersFinance Johnson & Johnson Innovation JJDC Inc (Johnson & Johnson Innovation JJDC) is a venture capital subsidiary of Johnson & Johnson founded in 1973. The firm is headquartered in New Brunswick, New Jersey. | Private Equity Investor | 01.02.2022 | - |
A2i Therapeutics Ltd.
 A2i Therapeutics Ltd. Investment ManagersFinance A2i Therapeutics Ltd. is an Israeli AI-based drug-design company that aims to develop novel therapeutic modulators of the protein ADAR1, a key element of the innate immune system. The company is a joint venture of the FutuRx Incubator and Atomwise, utilizing the AtomNet® AI platform and FutuRx’s technology to translate extraordinary technologies to life-changing therapies. | Direktor/Vorstandsmitglied | 01.01.2021 | - |
Protekt Therapeutics Ltd.
 Protekt Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Protekt Therapeutics Ltd. operates as a biopharmaceutical company. The firm develop a drug for enhancing the long-term memory of those suffering from mild cognitive impairment. The company is headquartered in Ness Ziona, Israel. | Direktor/Vorstandsmitglied | - | - |
FutuRx Ltd.
 FutuRx Ltd. Investment ManagersFinance FutuRx Ltd (FutuRx ) is a venture capital firm founded in 2014. The firm is headquartered in Ness Ziona. | Corporate Officer/Principal | 01.01.2019 | - |
Karriereverlauf von Lior Teitelbaum
Ehemalige bekannte Positionen von Lior Teitelbaum
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| Pg Medical Systems Ltd. | Direktor/Vorstandsmitglied | 01.01.2018 | 01.01.2019 |
| MindUP Ltd. | Gründer | 01.02.2016 | 01.12.2018 |
| Corporate Officer/Principal | 01.02.2016 | 01.12.2018 | |
| BIOLINERX LTD. | Private Equity Investor | 01.04.2012 | 01.05.2015 |
| Corporate Officer/Principal | 01.06.2015 | 01.02.2016 | |
| Metacure Israel Ltd. | Vertrieb & Marketing | 01.01.2010 | 01.01.2012 |
Ausbildung von Lior Teitelbaum
| Tel-Aviv University | Masters Business Admin |
| The Hebrew University of Jerusalem | Undergraduate Degree |
| Weizmann Institute of Science | Graduate Degree |
Statistik
International
| Israel | 11 |
| Vereinigte Staaten | 2 |
Operativ
| Director/Board Member | 3 |
| Corporate Officer/Principal | 3 |
| Private Equity Investor | 2 |
Sektoral
| Finance | 4 |
| Consumer Services | 4 |
| Health Technology | 3 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| BIOLINERX LTD. | Health Technology |
| Private Unternehmen | 7 |
|---|---|
Johnson & Johnson Innovation - JJDC, Inc.
Johnson & Johnson Innovation - JJDC, Inc. Investment ManagersFinance Johnson & Johnson Innovation JJDC Inc (Johnson & Johnson Innovation JJDC) is a venture capital subsidiary of Johnson & Johnson founded in 1973. The firm is headquartered in New Brunswick, New Jersey. | Finance |
FutuRx Ltd.
FutuRx Ltd. Investment ManagersFinance FutuRx Ltd (FutuRx ) is a venture capital firm founded in 2014. The firm is headquartered in Ness Ziona. | Finance |
| Metacure Israel Ltd. | |
Protekt Therapeutics Ltd.
Protekt Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Protekt Therapeutics Ltd. operates as a biopharmaceutical company. The firm develop a drug for enhancing the long-term memory of those suffering from mild cognitive impairment. The company is headquartered in Ness Ziona, Israel. | Health Technology |
| MindUP Ltd. | |
| Pg Medical Systems Ltd. | |
A2i Therapeutics Ltd.
A2i Therapeutics Ltd. Investment ManagersFinance A2i Therapeutics Ltd. is an Israeli AI-based drug-design company that aims to develop novel therapeutic modulators of the protein ADAR1, a key element of the innate immune system. The company is a joint venture of the FutuRx Incubator and Atomwise, utilizing the AtomNet® AI platform and FutuRx’s technology to translate extraordinary technologies to life-changing therapies. | Finance |
- Börse
- Insiders
- Lior Teitelbaum
- Erfahrung
